News outlets examine reaction to WHO plan to contain drug-resistant malaria

News outlets examine reaction to WHO plan to contain drug-resistant malaria
In follow-up coverage of the WHO’s announcement Wednesday of a plan to contain the spread of artemisinin-resistant malaria, news outlets examined the scope of the problem, reactions to the plan and speculations of how the anticipated $ 175 million annual cost would be funded.
Read more on News-Medical-Net

K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva(TM)
ST. LOUIS, Jan. 12, 2011 /PRNewswire/ — K-V Pharmaceutical Company (NYSE: KVa/KVb) today issued an update on the status of the U.S. Food and Drug Administration’s review of Hologic, Inc.’s (Hologic) New Drug Application (NDA) for Gestiva(TM) (hydroxyprogesterone caproate injection) as a treatment for the prevention of preterm birth in women with a singleton pregnancy who have a history of …
Read more on redOrbit

Survey: Exposure to Anti-Drug Messages Among Teens Drops Dramatically by Two-Thirds as Drug Use Goes Up
Slashed Prevention Funding and Drastic Reductions in Federal Media Campaign Add Pressure on Parents NEW YORK, Jan. 12, 2011 /PRNewswire-USNewswire/ — The University of Michigan’s Monitoring the Future study (MTF) – the largest survey on teen drug abuse tracking over 46,000 8th, 10th and 12th graders – found a huge falloff in teens’ recalled exposure to drug abuse prevention messages over the …
Read more on redOrbit